150 related articles for article (PubMed ID: 8313631)
21. A new liquid formulation of 8-methoxypsoralen: bioactivity and effect of diet.
Levins PC; Gange RW; Momtaz-T K; Parrish JA; Fitzpatrick TB
J Invest Dermatol; 1984 Feb; 82(2):185-7. PubMed ID: 6693780
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous photosensitization by 8-methoxypsoralen: order-dependent synergism between radiation less than 380 nm and broadband UVA.
Gange RW; Levins PC; Anderson RR; Parrish JA
J Invest Dermatol; 1984 Jun; 82(6):594-7. PubMed ID: 6725982
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
Cox NH; Farr PM; Diffey BL
Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
[TBL] [Abstract][Full Text] [Related]
24. Improved prediction of the minimal phototoxic dose in PUVA therapy.
Sakuntabhai A; Matthews JN; Farr PM
Br J Dermatol; 1994 May; 130(5):604-9. PubMed ID: 8204468
[TBL] [Abstract][Full Text] [Related]
25. Psoralen-containing sunscreen induces phototoxicity and epidermal ornithine decarboxylase activity.
Walter JF; Gange RW; Mendelson IR
J Am Acad Dermatol; 1982 Jun; 6(6):1022-7. PubMed ID: 7096664
[TBL] [Abstract][Full Text] [Related]
26. Ultraviolet A-induced photodegradation of 5-methoxypsoralen, 8-methoxypsoralen and psoralen reduces the biological effectiveness of the furocoumarins in vivo.
Knudsen EA; Bech-Thomsen N; Wulf HC
Photodermatol Photoimmunol Photomed; 1995 Jun; 11(3):131-3. PubMed ID: 8555012
[No Abstract] [Full Text] [Related]
27. Vemurafenib skin phototoxicity is indirectly linked to ultraviolet A minimal erythema dose decrease.
Brugière C; Stefan A; Morice C; Cornet E; Moreau A; Allouche S; Verneuil L
Br J Dermatol; 2014 Dec; 171(6):1529-32. PubMed ID: 25066094
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of skin phototoxicity study using SD rats by transdermal and oral administration.
Yonezawa Y; Ohsumi T; Miyashita T; Kataoka A; Hashimoto K; Nejishima H; Ogawa H
J Toxicol Sci; 2015 Dec; 40(6):667-83. PubMed ID: 26558448
[TBL] [Abstract][Full Text] [Related]
29. An action spectrum for 8-methoxypsoralen-sensitized inhibition of DNA synthesis in vivo.
Kaidbey KH
J Invest Dermatol; 1985 Aug; 85(2):98-101. PubMed ID: 4020166
[TBL] [Abstract][Full Text] [Related]
30. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
[TBL] [Abstract][Full Text] [Related]
31. Carcinogenic and melanogenic effects of a filtered metal halide UVA source and a tubular fluorescent UVA tanning source with or without additional solar-simulated UV radiation in hairless mice.
Bech-Thomsen N; Wulf HC
Photochem Photobiol; 1995 Oct; 62(4):773-9. PubMed ID: 7480154
[TBL] [Abstract][Full Text] [Related]
32. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis.
Markham T; Rogers S; Collins P
Arch Dermatol; 2003 Mar; 139(3):325-8. PubMed ID: 12622624
[TBL] [Abstract][Full Text] [Related]
33. Minimum erythema dose determination in individuals of skin type V and VI with diffuse reflectance spectroscopy.
Kollias N; Baqer A; Sadiq I
Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):249-54. PubMed ID: 7727281
[TBL] [Abstract][Full Text] [Related]
34. Carcinogenic potential of fluorescent UV tanning sources can be estimated using the CIE erythema action spectrum.
Bech-Thomsen N; Wulf HC
Int J Radiat Biol; 1993 Oct; 64(4):445-50. PubMed ID: 7901306
[TBL] [Abstract][Full Text] [Related]
35. Dose-response relations in phototoxicity due to 8-methoxypsoralen and UV-A in man.
Ljunggren B; Bjellerup M; Carter DM
J Invest Dermatol; 1981 Feb; 76(2):73-5. PubMed ID: 7462679
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema and skin photosensitization by polypodium leucotomos.
González S; Pathak MA
Photodermatol Photoimmunol Photomed; 1996 Apr; 12(2):45-56. PubMed ID: 8897589
[TBL] [Abstract][Full Text] [Related]
37. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
[TBL] [Abstract][Full Text] [Related]
38. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
Calzavara-Pinton P
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
[TBL] [Abstract][Full Text] [Related]
39. 5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo.
McNeely W; Goa KL
Drugs; 1998 Oct; 56(4):667-90. PubMed ID: 9806110
[TBL] [Abstract][Full Text] [Related]
40. Phototoxic contact dermatitis from 5-methoxypsoralen in aromatherapy oil.
Clark SM; Wilkinson SM
Contact Dermatitis; 1998 May; 38(5):289-90. PubMed ID: 9667455
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
